Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,401 | 281 | 98.2% |
| Education | $118.69 | 2 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $851.90 | 42 | $0 (2024) |
| UCB, Inc. | $824.53 | 33 | $0 (2024) |
| Janssen Biotech, Inc. | $687.49 | 30 | $0 (2024) |
| ABBVIE INC. | $638.91 | 29 | $0 (2024) |
| PFIZER INC. | $486.00 | 29 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $465.68 | 21 | $0 (2024) |
| Horizon Therapeutics plc | $420.73 | 12 | $0 (2023) |
| GlaxoSmithKline, LLC. | $307.05 | 11 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $215.04 | 9 | $0 (2024) |
| Lilly USA, LLC | $213.45 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,037 | 84 | Amgen Inc. ($417.22) |
| 2023 | $1,506 | 51 | AbbVie Inc. ($358.84) |
| 2022 | $1,036 | 52 | PFIZER INC. ($165.95) |
| 2021 | $924.02 | 46 | UCB, Inc. ($225.03) |
| 2020 | $426.23 | 23 | Amgen Inc. ($109.71) |
| 2019 | $574.20 | 26 | Horizon Therapeutics plc ($133.28) |
| 2017 | $16.96 | 1 | GlaxoSmithKline, LLC. ($16.96) |
All Payment Transactions
283 individual payment records from CMS Open Payments — Page 12 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/19/2019 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $26.75 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 09/13/2019 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $20.40 | General |
| Category: Immunology | ||||||
| 09/10/2019 | Horizon Therapeutics plc | PENNSAID (Drug) | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: PENNSAID | ||||||
| 08/27/2019 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: Immunology | ||||||
| 08/24/2019 | AbbVie, Inc. | Rinvoq (Biological) | Food and Beverage | In-kind items and services | $23.41 | General |
| Category: Immunology | ||||||
| 08/21/2019 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $17.28 | General |
| Category: Immunology | ||||||
| 08/12/2019 | Celgene Corporation | — | Food and Beverage | In-kind items and services | $18.85 | General |
| 02/24/2017 | GlaxoSmithKline, LLC. | BREO ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 600 | 52,301 | $1.0M | $509,497 |
| 2022 | 20 | 998 | 73,934 | $1.4M | $726,998 |
| 2021 | 23 | 1,090 | 51,517 | $744,206 | $457,849 |
| 2020 | 21 | 838 | 33,700 | $549,505 | $345,606 |
All Medicare Procedures & Services
77 procedure records from CMS Medicare Utilization — Page 3 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 76882 | Partial ultrasound of joint or other non-blood vessel structure of arm or leg | Office | 2021 | 14 | 15 | $1,125 | $746.09 | 66.3% |
| J3489 | Injection, zoledronic acid, 1 mg | Office | 2021 | 19 | 95 | $2,850 | $737.19 | 25.9% |
| 20600 | Aspiration and/or injection of small joint or joint capsule | Office | 2021 | 12 | 13 | $1,258 | $618.17 | 49.1% |
| 86226 | Measurement of dna antibody, single stranded | Office | 2021 | 37 | 37 | $555.00 | $435.96 | 78.6% |
| 86431 | Rheumatoid factor level | Office | 2021 | 58 | 58 | $464.00 | $328.86 | 70.9% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2021 | 40 | 165 | $442.20 | $166.88 | 37.7% |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2020 | 12 | 30,400 | $266,000 | $197,728 | 74.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 236 | 642 | $97,446 | $56,200 | 57.7% |
| J0897 | Injection, denosumab, 1 mg | Office | 2020 | 17 | 1,560 | $40,560 | $24,396 | 60.1% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 189 | 189 | $47,512 | $24,297 | 51.1% |
| 96401 | Non-hormonal anti-neoplastic chemotherapy beneath the skin or into muscle | Office | 2020 | 35 | 215 | $28,380 | $15,008 | 52.9% |
| 96413 | Infusion of chemotherapy into a vein up to 1 hour | Office | 2020 | 21 | 100 | $40,000 | $12,414 | 31.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 53 | 69 | $6,949 | $4,230 | 60.9% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 31 | 31 | $5,763 | $2,620 | 45.5% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 13 | 16 | $3,246 | $1,884 | 58.0% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2020 | 26 | 33 | $4,102 | $1,704 | 41.5% |
| 20600 | Aspiration and/or injection of small joint or joint capsule | Office | 2020 | 12 | 16 | $1,549 | $725.40 | 46.8% |
| J3489 | Injection, zoledronic acid, 1 mg | Office | 2020 | 16 | 80 | $2,400 | $717.13 | 29.9% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour | Office | 2020 | 11 | 11 | $1,440 | $694.21 | 48.2% |
| 82306 | Vitamin d-3 level | Office | 2020 | 21 | 21 | $728.00 | $621.60 | 85.4% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 13 | 21 | $720.00 | $572.92 | 79.6% |
| 76882 | Partial ultrasound of joint or other non-blood vessel structure of arm or leg | Office | 2020 | 12 | 13 | $975.00 | $548.10 | 56.2% |
| 83516 | Analysis of substance using immunoassay technique | Office | 2020 | 20 | 40 | $560.00 | $461.20 | 82.4% |
| 86200 | Measurement of antibody for rheumatoid arthritis assessment | Office | 2020 | 22 | 22 | $330.00 | $284.90 | 86.3% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2020 | 46 | 189 | $506.52 | $220.48 | 43.5% |
About Dr. Louis Robinett, M.D
Dr. Louis Robinett, M.D is a Rheumatology healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/03/2014. The National Provider Identifier (NPI) number assigned to this provider is 1780002956.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Louis Robinett, M.D has received a total of $6,520 in payments from pharmaceutical and medical device companies, with $2,037 received in 2024. These payments were reported across 283 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($6,401).
As a Medicare-enrolled provider, Robinett has provided services to 3,526 Medicare beneficiaries, totaling 211,452 services with total Medicare billing of $2.0M. Data is available for 4 years (2020–2023), covering 77 distinct procedure/service records.
Practice Information
- Specialty Rheumatology
- Location Austin, TX
- Active Since 04/03/2014
- Last Updated 04/28/2025
- Taxonomy Code 207RR0500X
- Entity Type Individual
- NPI Number 1780002956
Products in Payments
- Cimzia (Drug) $787.06
- KRYSTEXXA (Biological) $491.95
- XELJANZ (Drug) $452.98
- RINVOQ (Biological) $430.11
- TREMFYA (Drug) $352.88
- Enbrel (Biological) $248.12
- COSENTYX (Drug) $246.90
- ORENCIA (Biological) $211.94
- TALTZ (Drug) $192.26
- Otezla (Drug) $178.40
- OFEV (Drug) $175.34
- REMICADE (Biological) $174.69
- BENLYSTA (Biological) $168.26
- COSENTYX (Biological) $162.27
- TAVNEOS (Drug) $161.69
- EVENITY (Biological) $161.68
- KEVZARA (Biological) $137.58
- SKYRIZI (Biological) $137.15
- SAPHNELO (Biological) $125.06
- NUCALA (Biological) $121.83
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Rheumatology Doctors in Austin
Dr. Robert Koval, Md, MD
Rheumatology — Payments: $67,062
Paul Pickrell, Md, MD
Rheumatology — Payments: $29,321
Joseph Martinez, Md, MD
Rheumatology — Payments: $21,904
Marco Lopez Velazquez, M.d, M.D
Rheumatology — Payments: $3,941
Sonia Yousuf, Md, MD
Rheumatology — Payments: $2,974
Dr. Samir Patel, M.d, M.D
Rheumatology — Payments: $1,565